MAIN Medical imaging biz finds home
The diagnostic imaging arm of MAIN (Mid-Atlantic Imaging Network) Medical, a major network of freestanding medical imaging centers operating in the Mid-Atlantic region, has been acquired by a management and investment group. The group, which took
The diagnostic imaging arm of MAIN (Mid-Atlantic Imaging Network) Medical, a major network of freestanding medical imaging centers operating in the Mid-Atlantic region, has been acquired by a management and investment group. The group, which took ownership Aug. 16, is being led by MAIN's president and CEO, Anthony Geramita. Terms of the agreement have not been disclosed, but include acquisition of the five imaging centers, plus the Mobile Ultrasound Division, that the former company operated, as well as rights to the MAIN Medical name. The acquisition is a natural progression for MAIN Medical, according to Geramita, who has led the firm for the past two years. The Pittsburgh-based group plans to open more centers and develop partnerships with hospitals and other imaging providers in the region.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
